Summary :
Xebra Brands Ltd. , a cannabis company, is pleased to announce that it has satisfied all conditions pursuant to its agreement with New Age Nanotech, to license its clinically-backed, patent pending cannabinoid emulsion technology, Solutech™; to transform cannabis extracts into shelf-stable clear and odourless, water-soluble forms, ideal for the infusion of beverages, edibles and topicals.
Xebra Brands Ltd. (“Xebra”) (CSE: XBRA) (OTCQB: XBRAF) (FSE: 9YC), a cannabis company, is pleased to announce that it has satisfied all conditions pursuant to its agreement with New Age Nanotech, to license its clinically-backed, patent pending cannabinoid emulsion technology, Solutech™; to transform cannabis extracts into shelf-stable clear and odourless, water-soluble forms, ideal for the infusion of beverages, edibles and topicals. Many options were evaluated globally for cannabinoid delivery IP, and Xebra identified only one that has undergone human testing – Solutech™.
Solutech™ is one of the fastest-acting, most bioavailable and comprehensively studied delivery systems for cannabinoids, including THC and CBD, uniquely differentiated by the completion of a pioneering Phase-I human clinical trial. Xebra believes that as the cannabis industry develops, that consumers will demand better and safer products, and that claims about characteristics such as absorption, homogeneity, bioavailability, and shelf-life will be more closely scrutinized by regulators.
Xebra Brand Ltd, cannabis company
Xebra is aiming to utilize Solutech™ in the launch of its Vicious Citrus THC Lemonade in Canada, which is planned for the Spring of 2022. Xebra is also planning to outfit a facility in Mexico to produce Solutech™, a market where Xebra holds the exclusive licence. Xebra’s license is also exclusive in Colombia, and non-exclusive in Europe and the rest of the Americas, including Canada, but limited to California in the United States.
Xebra has fully paid the consideration for the right to produce and use Solutech™. The agreement is effective immediately with an indefinite perpetual term, unless terminated under specific circumstances.
ABOUT SOLUTECH™
Infusing cannabis into products presents three major challenges: limited shelf-stability, poor absorption, and inconsistent dosing. Solutech™ addresses these issues, and is also clear, pharmaceutical-grade, bioactive, and low-cost to produce.
Solutech™ can be produced in water soluble, water-free and dry formats and contains safe, vegan, kosher, allergen-free ingredients. Solutech™ also complies with all the main safety and testing protocols, including Good Manufacturing Practices (GMP) and The Global Safety Food Initiative (GFSI).
Solutech™ may be the only cannabinoid infusion technology that has undergone Phase-I human clinical trials for relative oral bioavailability and absorption, and it includes both major cannabinoids THC and CBD, and their metabolites. The Phase-I, Health Canada-approved study, was led by KGK Science, a premier clinical research organization. Solutech™ demonstrated dramatically increased speed of absorption and elimination (fast onset and offset of effects), peak blood levels and rate of absorption, along with a consistent and desirable consumer experience.
The Phase-I trial is complete and the results are expected to be published before April.
ABOUT XEBRA
Xebra is an absolute first mover in the Mexican cannabis sector, for hemp, CBD and CBG. Xebra has also been selected by the Dutch government, out of a competitive pool of applicants, as one of only five companies to compete for two exclusive licenses to cultivate THC medicinal cannabis in the Netherlands, with an initial six-year guaranteed government contract for each successful party, estimated at ~CDN$100 million. In Canada, Xebra plans to launch it’s Vicious Citrous THC Lemonade in the spring of 2022. In Colombia, Xebra is completing agronomical evaluations, to fully register cannabis seed varieties, in anticipation of commercial activities with THC in 2022.
ABOUT NEW AGE NANOTECH
New Age Nanotech is enabling the world’s most innovative, clinically-backed, and consumer-focused products to improve health and wellness through Solutech™, the company’s flagship water-soluble delivery technology for cannabinoids. Solutech™ offers a fully characterized pharmacokinetic and pharmacodynamic profile for consumer products to champion safe & effective use. New Age Nanotech offers Solutech™ to CPG brands for the development and commercialization of innovative, convenient, and controlled-dose products that speak to the evolving needs of their consumers.
